TY - JOUR AU - WANG Dong-yao AU - KOSOWAN Joel AU - SAMSOM James AU - LEUNG Laura AU - ZHANG Kai-lai AU - LI Ying-xiang AU - XIONG Yan AU - JIN Jian AU - PETRONIS Arturas AU - OH Gabriel AU - WONG Albert H C PY - 2018 TI - Inhibition of the G9a/GLP histone methyltransferase complex modulates anxiety-related behavior in mice JF - Acta Pharmacologica Sinica; Vol 39, No 5 (May 2018): Acta Pharmacologica Sinica (Special Issue on Frontier in Medical Research and Drug Development) Y2 - 2018 KW - N2 - Abstract Epigenetic gene-regulation abnormalities have been implicated in various neuropsychiatric disorders including schizophrenia and depression, as well as in the regulation of mood and anxiety. In addition, epigenetic mechanisms are involved in the actions of psychiatric drugs. Current anxiolytic drugs have significant shortcomings, and development of new medications is warranted. Two proteins, G9a (also known as EHMT2 or KMT1C) and GLP (G9a-like protein, also known as EHMT1 or KMT1D), which methylate lysine 9 of histone H3 (H3K9), could be promising anxiolytic targets. Postnatal genetic knock-out of G9a reduces anxiety-related behavior, consistent with the reduction of G9a levels by some medications used to treat anxiety (amitriptyline, imipramine and paroxetine). Conversely, there is increased anxiety-like behavior in mice with GLP haplodeficiency. We sought to determine whether two pharmacological inhibitors of G9a/GLP, UNC0642 and A-366, would have similar effects to genetic G9a/GLP insufficiency. We found that G9a/GLP inhibition with either compound reduced anxiety-like behaviors when administered to adult mice, in conjunction with decreased H3K9 methylation in the brain. In contrast, exposure to these compounds from embryonic day 9.5 (E9.5) until birth increased anxiety-like behaviors and decreased social interaction in adulthood, while H3K9 methylation was at normal levels in the brains of the adult mice. These findings reinforce genetic evidence that G9a/GLP has different effects on anxiety-like behavior at different stages of brain development, and suggest that targeting this histone methyltransferase pathway could be useful for developing new anxiolytic drugs. These data also suggest that antidepressant exposure in utero could have negative effects in adulthood, and further investigation of these effects is warranted. UR - http://www.chinaphar.com/article/view/9785